Author

Kai Fan Cheng

Feinstein Institute for Medical ResearchORCID 0000-0003-2704-652XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 1 Assay:perturbation screen· 1

Frequent Co-Authors

Mingzhu HeiD· 2 shared Ahmad S. AltitiiD· 1 shared Ankur GargiD· 1 shared Camila Gonzalez· 1 shared Christy Felice· 1 shared Darryl PappiniD· 1 shared Elad ElkayamiD· 1 shared Evdokia MichalopoulouiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Mingzhu HeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintNov 5, 2025

Novel small-molecule inhibitors of the protein kinase DYRK: Potential Therapeutic candidates in cancer

Prabhadevi Venkataramani, Elad Elkayam, Ankur Garg…·Nicholas K. Tonks

This study identifies two selective DYRK1A inhibitors, FC-2 and FC-3, which show antitumor effects in glioblastoma models.

DOI 10.1101/2025.11.05.686653

humanexperimental assay

𝕏 PostBluesky

BiochemistrybioRxivPreprintMar 3, 2025

A Plug-and-Play Platform for Automated Azapeptide Synthesis: Case study of Azapeptide-based GLP-1

Mingzhu He, Kai Fan Cheng, Yousef Al‐Abed

This paper introduces an automated platform for azapeptide synthesis that overcomes synthetic challenges by using pre-activated building blocks and microwave-assisted synthesis, enabling efficient and scalable production of stabilized peptide therapeutics.

3 citations

perturbation screenexperimental assay

𝕏 PostBluesky